glp 1 drugs and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential GLP-1 Use in Crohn's Disease:
Description
CONCLUSION Although more research and consensus are needed to determine the optimal length of time for holding GLP-1 receptor agonists before a procedure requiring anesthesia, it is important for practitioners and patients to be aware of the increased risks for aspiration and to consider strategies to mitigate harm
Oxyntomodulin analogue increases energy expenditure via the Gcg receptor
10.1016/j.neuro.2022.08.007 [DOI] [PubMed] [Google Scholar] 81.Jolivalt CG, Fineman M, Deacon CF, Carr RD, Calcutt NA (2011) GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice
Non-alcoholic fatty liver disease (NAFLD) can progress to NASH, a major risk factor for liver cancer [95]
